CHEN GUOQING PAUL has a total of 18 patent applications. Its first patent ever was published in 2004. It filed its patents most often in United States, Canada and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are C & C RES LAB, LIANG CONGXIN and BERGMAN JEFFREY M.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Canada | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Republic of Korea | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Australia | 1 | |
#7 | Brazil | 1 | |
#8 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Chen Guoqing Paul | 17 |
#2 | Paul Guoqing Chen | 1 |
Publication | Filing date | Title |
---|---|---|
US2012123126A1 | Compounds as c-Met kinase inhibitors | |
US2010048599A1 | Compounds as kinase inhibitors | |
US2008227811A1 | Spiro substituted compounds as angiogenesis inhibitors | |
US2008227812A1 | Spiro substituted compounds as angiogenesis inhibitors | |
US2007167470A1 | Spiro compounds and methods of use | |
CA2568608A1 | Six membered amino-amide derivatives as angiogenesis inhibitors |